SI
AMED

Sapience Investments’s Amedisys AMED Stock Holding History

Sapience Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-51,125
Closed -$4.78M – 82
2023
Q3 		$4.78M Sell
51,125
-1,250
-2% -$116K 1.15% 50
2023
Q2 		$4.79M Sell
52,375
-99,045
-65% -$8.13M 1.08% 50
2023
Q1 		$11.1M Buy
151,420
+37,380
+33% +$3.23M 2.57% 7
2022
Q4 		$9.53M Buy
114,040
+28,950
+34% +$2.61M 2% 18
2022
Q3 		$8.24M Buy
85,090
+20,235
+31% +$2.41M 1.73% 22
2022
Q2 		$6.82M Buy
+64,855
New +$8.29M 1.28% 42
2018
Q3 		– Sell
-86,235
Closed -$7.37M – 82
2018
Q2 		$7.37M Sell
86,235
-57,415
-40% -$4.22M 0.97% 49
2018
Q1 		$8.67M Buy
143,650
+1,400
+1% +$79.7K 1.19% 40
2017
Q4 		$7.5M Buy
142,250
+41,055
+41% +$2.16M 1.01% 45
2017
Q3 		$5.66M Buy
101,195
+3,950
+4% +$209K 0.79% 55
2017
Q2 		$6.11M Sell
97,245
-58,770
-38% -$3.42M 0.96% 56
2017
Q1 		$7.97M Buy
156,015
+38,415
+33% +$1.83M 1.31% 40
2016
Q4 		$5.01M Buy
+117,600
New +$5M 1.54% 29

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Sapience Investments's AMED Position: Q4 2023 in Review

Sapience Investments sold out of Amedisys (AMED) in Q4 2023, closing a stake of 51,125 shares — an estimated $4.78M sold.

Sapience Investments first reported a position in AMED in Q4 2016 and held it in 13 quarters. The position peaked at $11.1M in Q1 2023. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Sapience Investments reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Sapience Investments sold 51,125 Amedisys shares in Q4 2023, an estimated $4.78M.
  • Sapience Investments first reported a position in Amedisys in Q4 2016 and held it in 13 quarters.
  • Sapience Investments's Amedisys position peaked at $11.1M in Q1 2023.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Sapience Investments's 13F filing for Q4 2023, filed 14 Feb 2024.